| All Releases |
 |
September 10, 2009
Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents |
 |
 |
| |
ARDEE, Ireland, Sept 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that one of its subsidiaries has filed two lawsuits against Lupin Limited and its wholly owned subsidiary Lupin Pharmaceuticals, Inc. (collectively "Lupin") in the District Court for the District of Delaware for infring... |
|
|
August 24, 2009
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business |
|
|
| |
CINCINNATI and ARDEE, Ireland, Aug 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The Procter & Gamble Company (NYSE: PG) and Warner Chilcott plc (Nasdaq: WCRX) today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash payment of $3.1 billion.
To view the Multimedia News ... |
|
|
August 21, 2009
Warner Chilcott Completes Irish Redomestication |
|
|
| |
ARDEE, Ireland, Aug 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott (Nasdaq: WCRX) announced today that its redomestication has been completed and the ultimate public holding company of the Warner Chilcott group is now organized in, and a tax resident of, Ireland. The transaction was completed on August 20, 2009, followi... |
|
|
August 7, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance |
|
|
| |
ARDEE, Ireland, Aug 07, 2009 /PRNewswire-Firstcall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended June 30, 2009. Revenue in the quarter ended June 30, 2009 increased 7.1% to $250.8 million over the prior year quarter. The primary drivers of the increase in revenue were the net sa... |
|
|
August 5, 2009
Warner Chilcott Announces Shareholder Approval of Irish Redomestication |
|
|
| |
ARDEE, Ireland, Aug 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that at a special court-ordered meeting of shareholders held earlier today (the "Special Meeting"), its shareholders approved a scheme of arrangement between the Company and its shareholders. Assuming receipt of the... |
|
|
August 3, 2009
Warner Chilcott Announces Receipt of Paragraph IV Certification Notices |
|
|
| |
ARDEE, Ireland, Aug 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has received two Paragraph IV Certification Notices from Lupin Ltd. ("Lupin"). The Paragraph IV Certification Notices advise the Company of the filing of Abbreviated New Drug Applications (ANDAs) by Lupin fo... |
|
|
July 14, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results |
|
|
| |
ARDEE, Ireland, July 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its second quarter 2009 financial results prior to the market opening on Friday, August 7, 2009.
In addition to issuing a press release, the Company will host a conference call for all interested... |
|
|
June 26, 2009
Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered Meeting of Shareholders |
|
|
| |
ARDEE, Ireland, June 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited announced today that it will hold its 2009 Annual General Meeting of Shareholders (the "Annual Meeting") and a Special Court-Ordered Meeting of Shareholders (the "Special Meeting") on August 5, 2009. At the Special Meeting, the Company's shareho... |
|
|
June 19, 2009
Warner Chilcott to Present at Wachovia's 19th Annual Mid-Year Equity Conference |
|
|
| |
ARDEE, Ireland, June 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at Wachovia's 19th Annual Mid-Year Equity Conference on Wednesday, June 24, 2009 at 2:30 p.m. ET. Presenting for Warner Chilcott will be Rochelle Fuhrmann, Senior Director, Investor Relations.
... |
|
|
June 8, 2009
Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference |
|
|
| |
ARDEE, Ireland, June 8, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 10:20 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Executive Off... |
|
|
May 27, 2009
Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive |
|
|
| |
ARDEE, Ireland, May 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that the U.S. Food and Drug Administration (FDA) has filed for standard review the new drug application (NDA) for WC 3016, a low dose oral contraceptive. The NDA for WC 3016 was submitted by its subsidiary, Warner C... |
|
|
May 11, 2009
Warner Chilcott Proposes Redomestication From Bermuda to Ireland |
|
|
| |
ARDEE, Ireland, May 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that its Board of Directors has unanimously approved the redomestication of the Company from Bermuda to Ireland. Subject to the approval of a scheme of arrangement by the Company's stockholders and the approval of th... |
|
|
May 11, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance |
|
|
| |
ARDEE, Ireland, May 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2009. Revenue in the quarter ended March 31, 2009 totaled $246.0 million, an increase of 7.2% over the prior year quarter. The primary drivers of the increase in revenue we... |
|
|
May 7, 2009
Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference |
|
|
| |
HAMILTON, BERMUDA, May 7, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Bank of America and Merrill Lynch Healthcare Conference on Tuesday, May 12, 2009 at 10:00 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Execut... |
|
|
May 1, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, May 1, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Mylan Pharmaceuticals Inc. and Mylan Inc. ("Mylan") in the District Court for the District of New ... |
|
|
April 27, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results |
|
|
| |
HAMILTON, Bermuda, April 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its first quarter 2009 financial results prior to the market opening on Monday, May 11, 2009.
In addition to issuing a press release, the Company will host a conference call for all intereste... |
|
|
March 27, 2009
Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive |
|
|
| |
HAMILTON, Bermuda, March 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that its affiliate, Warner Chilcott Company Inc. has submitted a New Drug Application for WC 3016, a low-dose oral contraceptive, to the U.S. Food and Drug Administration.
About Warner Chilcott
Warner Chilcott... |
|
|
March 19, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, March 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for inf... |
|
|
March 17, 2009
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
|
|
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has received the FDA's response to its citizen petition requesting that the FDA impose a 30-month stay of approval on Abbreviated New Drug Applications ("ANDAs") referencing DORYX 100 and 75 mg delayed r... |
|
|
March 17, 2009
Warner Chilcott Announces Receipt of Paragraph IV Certification Notice |
|
|
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have received a Paragraph IV Certification Notice from Impax Laboratories, Inc. ("Impax") advising that Impax has filed an Abbrevia... |
|
|
|
Investor Relations
